WFM
PBYI icon

Wilmington Funds Management’s Puma Biotechnology PBYI Stock Holding History

Wilmington Funds Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$267K Hold
4,050
– – 0.03% 577
2014
Q1 		$422K Buy
4,050
+1,770
+78% +$208K 0.05% 414
2013
Q4 		$236K Buy
+2,280
New +$134K 0.02% 644

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wilmington Funds Management's PBYI Position: Q2 2014 in Review

Wilmington Funds Management held its Puma Biotechnology (PBYI) position steady in Q2 2014 at 4,050 shares worth $267K. The position accounts for 0.03% of the portfolio, ranked #577.

Wilmington Funds Management first reported a position in PBYI in Q4 2013 and has held it in 3 quarters since. The position peaked at $422K in Q1 2014. 138 funds tracked by Wall St. Rank hold PBYI as of Q2 2014.

  • Wilmington Funds Management held 4,050 shares of Puma Biotechnology worth $267K as of Q2 2014.
  • Wilmington Funds Management left its Puma Biotechnology share count unchanged in Q2 2014.
  • Puma Biotechnology made up 0.03% of Wilmington Funds Management's portfolio in Q2 2014, its #577 holding.
  • Wilmington Funds Management first reported a position in Puma Biotechnology in Q4 2013 and has held it in 3 quarters since.
  • Wilmington Funds Management's Puma Biotechnology position peaked at $422K in Q1 2014.
  • 138 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2014.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.